Community Research and Development Information Service - CORDIS

The next generation epigenetic medicine for inflammation

From 2015-01-01 to 2018-12-31, ongoing project

Project details

Total cost:

EUR 1 294 785

EU contribution:

EUR 1 294 785

Coordinated in:

Netherlands

Call for proposal:

H2020-MSCA-ITN-2014See other projects for this call

Funding scheme:

MSCA-ITN-EID - European Industrial Doctorates

Objective

Coordinator

Academisch Medisch Centrum bij de Universiteit van Amsterdam
Netherlands

EU contribution: EUR 1 021 497,12


MEIBERGDREEF 9
1105AZ AMSTERDAM
Netherlands
Activity type: Higher or Secondary Education Establishments

Participants

Glaxosmithkline Research and Development LTD
United Kingdom

EU contribution: EUR 273 287,88


Great West Road
TW8 9GS Brentford, Middlesex
United Kingdom
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Record Number: 193846 / Last updated on: 2016-11-21